About the Company


This American biotechnology company manufactures drug therapies for cancer and inflammatory disorders. The company is building a preeminent global biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for unmet medical needs in cancer and immune-inflammatory diseases.

The Business Challenges & 2nd Watch Solution

When the biotechnology company needed faster go-to-market times in order to release new drugs to the public more quickly and better high performance computing (HPC) capabilities to support its pharmaceutical researchers, the company partnered with AWS and 2nd Watch. 2nd Watch performed an application readiness assessment and assisted with the migration to AWS, enabling the company to run numerous HPC workloads on hundreds of Amazon EC2 instances.

Once the new highly scalable environment was up and running, the company could reduce the time it took to complete HPC jobs for drug research from weeks or months to just hours, but it still needed a way to further reduce spending. 2nd Watch recommended resizing its architecture and using AWS Trusted Advisor reporting to optimize its workloads. The biotechnology company also uses the 2nd Watch Cloud Management Platform optimization tool for added resource and cost management.

The Business Benefits

With the cloud optimization recommendations in place and by using Reserved Instance purchase planning, changing instance types and families, and purging EBS volumes the biotechnology company realized a $150,000 monthly cost reduction. The company also reduced costs on two applications by 40% following 2nd Watch’s recommended Reserved Instance program.

Get White Paper

Download the Enabling Enterprise Adoption - Build or Buy Considerations white paper